Alvotech ( ALVOW) - Key Metrics
ALVOW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.30 | -$0.19 | -$0.06 | -$0.13 |
| 2026Q1 | $0.32 | $0 | -$0.18 | -$0.32 |
| 2025Q4 | $0.60 | -$0.39 | -$0.23 | -$0.26 |
| 2025Q3 | $0.38 | -$0.02 | -$0.19 | -$0.25 |
| 2025Q2 | $0.62 | $0.11 | $0.20 | $0.15 |
ALVOW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.86 |
| 2026Q1 | 0% | 276.61 |
| 2025Q4 | 0% | -3.38 |
| 2025Q3 | 0% | -117.67 |
| 2025Q2 | 0% | 20.73 |
ALVOW
Price: $0.30
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 3.0 billion